Cannon Financial Strategists, Inc. Abb Vie Inc. Transaction History

Cannon Financial Strategists, Inc.

$572 Billion
Q3 2024

A detailed history of Cannon Financial Strategists, Inc. transactions in Abb Vie Inc. stock. As of the latest transaction made, Cannon Financial Strategists, Inc. holds 4,044 shares of ABBV stock, worth $716,030. This represents 0.14% of its overall portfolio holdings.

Number of Shares

4,044

Previous 4,007 0.92%

Holding current value

$716,030

Previous $621 Million 28.61%

% of portfolio

0.14%

Previous 0.13%

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 21, 2024	BUY	$163.84 - $199.33 $6,062 - $7,375	37 Added 0.92%	4,044 $799 Million
Q2 2024 Sep 10, 2024	BUY	$154.79 - $180.76 $635,722 - $742,381	4,107 New	4,107 $704 Million
Q1 2024 Oct 01, 2024	SELL	$159.82 - $182.1 $419 Million - $478 Million	-2,623,248 Reduced 99.84%	4,107 $748 Million
Q4 2023 Oct 18, 2024	SELL	$137.6 - $154.97 $13,760 - $15,497	-100 Reduced 2.43%	4,007 $621 Million
Q4 2023 Oct 01, 2024	BUY	$137.6 - $154.97 $361 Million - $407 Million	2,623,248 Added 63872.61%	2,627,355 $67.1 Billion
Q3 2023 Oct 18, 2024	BUY	$133.59 - $154.65 $8,416 - $9,742	63 Added 1.6%	4,007 $597 Million
Q3 2023 Oct 02, 2024	SELL	$133.59 - $154.65 $526,878 - $609,939	-3,944 Closed	0 $0
Q1 2023 Oct 02, 2024	SELL	$144.61 - $166.54 $23,571 - $27,146	-163 Reduced 3.97%	3,944 $629 Million
Q4 2022 Oct 18, 2024	SELL	$138.31 - $165.87 $8,713 - $10,449	-63 Reduced 1.57%	3,944 $637 Million
Q3 2022 Oct 18, 2024	SELL	$134.21 - $153.93 $28,452 - $32,633	-212 Reduced 5.1%	3,944 $529 Million
Q2 2022 Oct 18, 2024	BUY	$137.62 - $174.96 $12,385 - $15,746	90 Added 2.21%	4,156 $637 Million
Q1 2022 Oct 18, 2024	BUY	$131.98 - $163.75 $20,588 - $25,545	156 Added 3.99%	4,066 $659 Million
Q4 2021 Oct 18, 2024	SELL	$107.43 - $135.93 $10,420 - $13,185	-97 Reduced 2.42%	3,910 $529 Million
Q1 2021 Oct 02, 2024	BUY	$102.3 - $112.62 $399,993 - $440,344	3,910 New	3,910 $423 Million
Q4 2020 Oct 18, 2024	SELL	$80.49 - $108.67 $7,807 - $10,540	-97 Reduced 2.42%	3,910 $419 Million
Q4 2020 Oct 02, 2024	SELL	$80.49 - $108.67 $323,730 - $437,070	-4,022 Closed	0 $0
Q3 2020 Oct 02, 2024	SELL	$85.91 - $100.83 $7,302 - $8,570	-85 Reduced 2.07%	4,022 $352 Million
Q4 2019 Oct 18, 2024	SELL	$72.13 - $90.25 $6,996 - $8,754	-97 Reduced 2.42%	3,910 $346 Million
Q4 2019 Oct 02, 2024	SELL	$72.13 - $90.25 $282,028 - $352,877	-3,910 Closed	0 $0
Q1 2019 Oct 02, 2024	SELL	$77.14 - $90.79 $15,196 - $17,885	-197 Reduced 4.8%	3,910 $315 Million

Others Institutions Holding ABBV

# of Institutions

3,848

Shares Held

1.25B

Call Options Held

16.8M

Put Options Held

12.2M

View Full List

About AbbVie Inc.

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $313B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

More about ABBV

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Cannon Financial Strategists, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Cannon Financial Strategists, Inc. with notifications on news.

Account

Cannon Financial Strategists, Inc. Abb Vie Inc. Transaction History